Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
54.03
+0.51 (0.95%)
Aug 10, 2026, 11:43 AM EDT - Market open

CRISPR Therapeutics AG Revenue by Segment

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Grant
3.10M3.51M3.34M3.05M2.68M2.31M2.83M2.23M
Grant Growth
16.00%51.69%17.96%36.96%56.43%91.87%--
Collaboration
1.00M-35.00M35.00M35.00M35.00M200.00M200.00M
Collaboration Growth
-97.14%--82.50%-82.50%-87.04%-90.54%17.64%17.58%

Operating Expense Breakdown

Period EndingMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Research and Development
280.90M284.81M283.44M306.69M316.96M320.65M333.64M342.18M
Research and Development Growth
-11.38%-11.18%-15.05%-10.37%-12.82%-17.22%-15.69%-18.85%
Collaboration
201.92M213.48M170.19M124.23M131.21M120.67M130.25M142.52M
Collaboration Growth
53.89%76.92%30.67%-12.83%-2.82%-7.36%11.26%7.55%
General and Administrative
71.43M73.54M73.27M73.76M74.32M72.98M71.33M72.20M
General and Administrative Growth
-3.89%0.77%2.71%2.15%3.57%-4.18%-11.77%-19.38%